Multilayered Microparticles for Controlled Release of Active Compounds
Summary
The USPTO has published a new patent application (US20260083713A1) detailing multilayered microparticles for controlled release of active compounds in liquid dosage forms. The application was filed on October 21, 2025, by inventors from Belgium.
What changed
This document is a publication of a patent application filed with the USPTO, specifically application number US20260083713A1, titled 'Multilayered microparticles for controlled release of active compounds'. The application describes a novel microparticle technology designed for controlled release of pharmaceutically active compounds, intended for oral or direct gastric administration in liquid pharmaceutical compositions. It also covers related liquid and solid compositions, preparation kits, and manufacturing processes.
As this is a patent application publication, it does not impose immediate regulatory obligations or compliance deadlines on pharmaceutical companies. However, it signifies potential future intellectual property developments in drug delivery systems. Companies operating in the pharmaceutical manufacturing sector should be aware of this publication as it may relate to their research and development pipelines or existing patent portfolios.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM
Application US20260083713A1 Kind: A1 Mar 26, 2026
Inventors
Geoffrey DE BILDE, Pierre SACRE, Jonathan GOOLE, Karim AMIGHI, Olivier LALOUX, Georges GUILLAUME, Vincent STEPHENNE
Abstract
The present invention concerns controlled-release multilayer microparticle containing a pharmaceutically active compound, said microparticle being intended for oral administration or direct administration in the stomach in the form of a liquid pharmaceutical composition. It concerns also the liquid pharmaceutical composition containing it, a kit for the preparation of said liquid pharmaceutical composition, a pharmaceutical solid composition intended to be reconstituted in the form of said liquid composition and a process of preparation of said liquid composition.
CPC Classifications
A61K 31/4439 A61K 9/501 A61K 9/5015 A61K 9/5026 A61K 9/5073
Filing Date
2025-10-21
Application No.
19364681
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.